ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients

ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients MONTREAL, Sept. 4, 2019 /CNW Telbec/ – Servier Canada announces one-year outcomes results from a study of 24,962 patients with non-valvular atrial fibrillation (NVAF) treated with LIXIANA® (Edoxaban), including elderly NVAF patients and those with … Continue reading ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly Non-Valvular Atrial Fibrillation Patients

Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs

Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs TORONTO, Sept. 5, 2019  /CNW/ – Today, Crohn’s and Colitis Canada released their updated Position on biosimilar drugs. Supporting studies, including a report on cross-Canada surveys of patients and caregivers, gastroenterologists and inflammatory bowel disease (IBD) nurses was also released. “Crohn’s and Colitis Canada is a research-based … Continue reading Crohn’s and Colitis Canada Announces Updated Position Statement on Biosimilar Drugs

How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem

How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem VANCOUVER, Sept. 5, 2019 /CNW/ – A recent Arthritis Research Canada study has revealed that while administrative health databases are increasingly being used to study mental health in rheumatic diseases, researchers have used different ways to identify patients who … Continue reading How Common are Mental Health Problems in Arthritis Patients? Research Reveals Flaw in Determining Extent of Problem

Fighting frostbite: focusing on prevention and early drug treatment are the keys to success

Fighting frostbite: focusing on prevention and early drug treatment are the keys to success The Physiological Society – Press release For immediate release – 3 September 2019 Frostbite is an injury which usually affects the extremities,  such as fingers and toes, and has the potential of causing irreversible tissue loss. The treatment of freezing cold … Continue reading Fighting frostbite: focusing on prevention and early drug treatment are the keys to success

ProMIS Neurosciences to Present at HC Wainwright Investment Conference

ProMIS Neurosciences to Present at HC Wainwright Investment Conference Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, MA, Sept. 3, 2019 /CNW/ – ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative … Continue reading ProMIS Neurosciences to Present at HC Wainwright Investment Conference